Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Y.A.C.HOLDINGS CO.,LTD. ( (JP:6298) ).
Y.A.C. HOLDINGS CO., LTD. announced corrections to its joint venture establishment plan with Linus Biotechnology, Inc., initially disclosed in November 2024. The delays in finalizing agreements have postponed the joint venture’s timeline, with services now expected to launch in July 2025. The company assures stakeholders that these changes will not impact the financial results for the fiscal year ending March 2025, and any future financial implications will be communicated promptly.
More about Y.A.C.HOLDINGS CO.,LTD.
Y.A.C. HOLDINGS CO., LTD. operates in the biotechnology industry, focusing on innovative health solutions. It is involved in the development of autism analysis services through its subsidiary YAC BIO, INC., in collaboration with Linus Biotechnology, Inc.
Average Trading Volume: 111,833
Technical Sentiment Signal: Sell
Current Market Cap: Yen16.06B
Find detailed analytics on 6298 stock on TipRanks’ Stock Analysis page.